Ticker > Company >

Gian Life Care share price

Gian Life Care Ltd.

BSE: 542918 SECTOR: Hospital & Healthcare Services  16.44 K   61   3

14.98
+0.54 (3.74%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 14.99

Today's Low

₹ 13.72

52 Week High

₹ 24.44

52 Week Low

₹ 12.06

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

15.49 Cr.

Enterprise Value

13.69 Cr.

No. of Shares

1.03 Cr.

P/E

148.91

P/B

0.78

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  19.16

CASH

5.97 Cr.

DEBT

4.17 Cr.

Promoter Holding

32.09 %

EPS (TTM)

₹  0.1

Sales Growth

10.02%

ROE

24.59 %

ROCE

29.24%

Profit Growth

241.62 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year10.02%
3 Year7.86%
5 Year88.02%

Profit Growth

1 Year241.62%
3 Year28.65%
5 Year111.96%

ROE%

1 Year24.59%
3 Year23.37%
5 Year24.5%

ROCE %

1 Year29.24%
3 Year31.62%
5 Year34.65%

Debt/Equity

0.2124

Price to Cash Flow

20.59

Interest Cover Ratio

13.5014

CFO/PAT (5 Yr. Avg.)

1.01239494311518

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 32.09 61.17
Mar 2025 32.09 61.17
Dec 2024 32.09 61.17
Sep 2024 31.99 62.27
Jun 2024 32.82 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 23.367469310389% over the past 3 years.
  • Company has been maintaining healthy ROCE of 31.6226129876966% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 13.5014.
  • The Company has been maintaining an effective average operating margins of 34.3022303345062% in the last 5 years.
  • Company’s PEG ratio is 0.616296073287507.
  • The company has an efficient Cash Conversion Cycle of -478.2375 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.01239494311518.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 7.73993196385892.

 Limitations

  • The company has shown a poor revenue growth of 7.86173384300266% for the Past 3 years.
  • Promoter pledging is high as 61.17%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 1.98 1.95 1.59 1.11 0.87
Total Expenditure 1.76 1.72 1.11 1.11 0.73
Operating Profit 0.22 0.22 0.48 0 0.13
Other Income 0.17 0.16 0.16 -0.25 0.16
Interest 0.11 0.1 0.1 0.1 0.09
Depreciation 0.12 0.12 0.12 0.12 0.11
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.17 0.17 0.42 -0.46 0.08
Tax 0.06 0.03 0.04 0.02 0.03
Profit After Tax 0.11 0.14 0.38 -0.48 0.05
Adjusted EPS (Rs) 0.1 0.14 0.37 -0.46 0.05

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 7.65 10.46 15.93 11.92 13.12
Total Expenditure 5.33 6.98 9 9.88 6.91
Operating Profit 2.32 3.48 6.93 2.04 6.21
Other Income 0.1 0.29 0.51 0.69 0.64
Interest 0.61 0.73 1.25 0.45 0.47
Depreciation 0.26 0.29 0.33 0.5 0.46
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.56 2.75 5.85 1.79 5.91
Tax 0.43 0.74 1.48 0.53 1.62
Net Profit 1.13 2.02 4.37 1.26 4.3
Adjusted EPS (Rs.) 1.09 1.95 4.23 1.22 4.15

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 4.7 4.7 10.34 10.34 10.34
Total Reserves 2.94 4.96 3.69 4.97 9.27
Borrowings 0.75 0.62 1.87 1.65 1.8
Other N/C liabilities 0.17 0.17 0.26 0.7 1.04
Current liabilities 3.81 5.03 6.9 10.74 9.62
Total Liabilities 12.37 15.48 23.06 28.4 32.07
Assets
Net Block 2.84 2.99 3.5 4.62 4.47
Capital WIP 0 0 0.12 0.14 0.14
Intangible WIP 0 0 0 0 0
Investments 0 0 0.11 0.11 0.11
Loans & Advances 5.44 6.46 8.73 11.76 13.76
Other N/C Assets 0 0 0.29 0.3 0.41
Current Assets 4.09 6.03 10.31 11.48 13.18
Total Assets 12.37 15.48 23.06 28.4 32.07
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 1.56 2.75 5.85 1.79 5.91
Adjustment 0.6 0.42 1.93 0.26 0.28
Changes in Assets & Liabilities -0.42 -0.01 -1.32 0.3 -5.42
Tax Paid -0.23 -0.3 -0.67 -0.02 -0.02
Operating Cash Flow 1.51 2.87 5.79 2.32 0.75
Investing Cash Flow -3.96 -1.1 -4.23 -0.94 0.33
Financing Cash Flow 2.55 -0.39 0.67 -0.37 -0.86
Net Cash Flow 0.1 1.38 2.23 1.01 0.22

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 32.82 31.99 32.09 32.09 32.09
arun kumar gupta 29.73 28.89 29.00 29.00 29.00
avani gupta 2.24 2.24 2.24 2.24 2.24
devang agarwal 0.42 0.42 0.42 0.42 0.42
rashika agarwal 0.42 0.42 0.42 0.42 0.42
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 67.18 68.01 67.91 67.91 67.91
gopal dnyandeo ingle - - - 1.69 1.69
mangesh kisanrao gotmare - - - 1.93 1.93
n mohan neela judith - 2.77 2.74 2.71 2.55
prashant prithviraj jain 1.11 1.11 1.09 1.10 1.08
shield multistate coopera... 6.55 6.49 6.49 6.49 6.49
sukhdev singh - - 1.33 1.06 1.11
tejesh hasmukh shah - 3.64 3.96 6.31 6.33
sundiip devaadigaa 9.67 3.69 3.69 - -
rahul govind binnani - 1.06 - - -

Annual Reports

Title Link
Title Link
Annual Report 2022
Annual Report 2021

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q2FY22

Gian Life Care Stock Price Analysis and Quick Research Report. Is Gian Life Care an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Gian Life Care. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Gian Life Care has a PE ratio of 148.906560636183 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Gian Life Care has ROA of 14.2066% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Gian Life Care has a Current ratio of 1.3707.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Gian Life Care has a ROE of 24.5947%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Gian Life Care has a Debt to Equity ratio of 0.2124 which means that the company has low proportion of debt in its capital.

  • Sales growth: Gian Life Care has reported revenue growth of 10.0221% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Gian Life Care for the current financial year is 47.2972148965686%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Gian Life Care is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Gian Life Care is Rs 0.1006. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Gian Life Care in Ticker for free. Also, one can get the intrinsic value of Gian Life Care by using Valuation Calculators, which are available with a Finology ONE subscription. 

Gian Life Care FAQs

Q1. What is Gian Life Care share price today?
Ans: The current share price of Gian Life Care is Rs 14.98.

Q2. What is the market capitalisation of Gian Life Care?
Ans: Gian Life Care has a market capitalisation of Rs 15.491602952 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Gian Life Care?
Ans: The PE ratio of Gian Life Care is 148.906560636183 and the P/B ratio of Gian Life Care is 0.781710683553287, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Gian Life Care share?
Ans: The 52-week high share price of Gian Life Care is Rs 24.44, and the 52-week low share price of Gian Life Care is Rs 12.06.

Q5. Does Gian Life Care pay dividends?
Ans: Currently, Gian Life Care does not pay dividends. Dividend yield of Gian Life Care is around 0%.

Q6. What are the face value and book value of Gian Life Care shares?
Ans: The face value of Gian Life Care shares is Rs 10, while the book value per share of Gian Life Care is around Rs 19.1631. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Gian Life Care?
Ans: Gian Life Care has a total debt of Rs 4.1669 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Gian Life Care?
Ans: The ROE of Gian Life Care is 24.5947% and ROCE of Gian Life Care is 29.2397%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Gian Life Care a good buy for the long term?
Ans: The Gian Life Care long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Gian Life Care undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Gian Life Care appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Gian Life Care’s financials?
Ans: You can review Gian Life Care’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Gian Life Care
X